![Kate Plumridge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Kate Plumridge
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kate Plumridge
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The University of New Mexico | College/University | Undergraduate Degree | |
Baylor College of Medicine | College/University | Doctorate Degree | |
Flamingo Therapeutics BV
![]() Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Director/Board Member | |
Hereditary Disease Foundation | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 7 |
Belgien | 2 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Distribution Services | 2 |
Commercial Services | 2 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
C. Bennett | 8 |
- Börse
- Insiders
- Kate Plumridge
- Unternehmensverbindungen